|
Volumn 36, Issue SUPPL. 1, 2007, Pages 45-52
|
Levemir® Early Clinical Experience Case Series
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EXENDIN 4;
GLIBENCLAMIDE;
GLIBENCLAMIDE PLUS METFORMIN;
GLIMEPIRIDE;
HUMAN INSULIN;
INSULIN ASPART;
INSULIN DETEMIR;
INSULIN GLARGINE;
INSULIN LISPRO;
ISOPHANE INSULIN;
METFORMIN;
MIGLITOL;
PIOGLITAZONE;
REPAGLINIDE;
ANTIDIABETIC AGENT;
DRUG DERIVATIVE;
INSULIN;
ADULT;
AGED;
ARTICLE;
CASE STUDY;
CLINICAL ARTICLE;
COMBINATION CHEMOTHERAPY;
DIET RESTRICTION;
DRUG DOSE INCREASE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EXPERIENCE;
FEMALE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HUMAN;
HYPOGLYCEMIA;
MALE;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
TREATMENT WITHDRAWAL;
WEIGHT REDUCTION;
CASE REPORT;
MIDDLE AGED;
REVIEW;
UNITED STATES;
AGED;
AGED, 80 AND OVER;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MALE;
MIDDLE AGED;
UNITED STATES;
|
EID: 34548573572
PISSN: 08898529
EISSN: None
Source Type: Journal
DOI: 10.1016/S0889-8529(07)80007-7 Document Type: Article |
Times cited : (1)
|
References (8)
|